Friend to all, enemy to none: the Philippines’ attempts at managing the reverse moral hazard
China International Strategy Review · 19.11.2026
DOI: 10.1007/s42533-026-00222-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift China International Strategy Review, online erschienen am 19.11.2026. Verfasst von Miguel Alberto Gomez. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Relative to other U.S. allies in the region, the Philippines is especially exposed to the risks of a reverse moral hazard. Given its historical dependence on the United States for its territorial defense due to enduring material deficiencies and latent vulnerabilities, one would expect its leadership to readily acquiesce to the demands of its patron. Nonetheless, recent history sees an attempt to push for greater agency in the country’s affairs within the region. Specifically, the country’s leadership continues to frame its foreign policy choices, from its recourse to international law to the modernization of its armed forces, as self-determined and in keeping with its own interests irrespective of emergent great-power competition. While laudable, such actions test the limits of Manila’s flexibility, highlighting the gaps in its strategy which may ultimately encourage the current or future administration to be more accommodating of the demands imposed by Washington.
Zitieren
APA
Gomez, M. A. (2026). Friend to all, enemy to none: the Philippines’ attempts at managing the reverse moral hazard. China International Strategy Review. https://doi.org/10.1007/s42533-026-00222-2
Vancouver
Gomez MA. Friend to all, enemy to none: the Philippines’ attempts at managing the reverse moral hazard. China International Strategy Review. 2026. doi:10.1007/s42533-026-00222-2
BibTeX
@article{Gomez2026,
author = {Gomez, Miguel Alberto},
title = {Friend to all, enemy to none: the Philippines’ attempts at managing the reverse moral hazard},
journal = {China International Strategy Review},
year = {2026},
doi = {10.1007/s42533-026-00222-2}
}
EUVIMED